BACKGROUND: Adherence to TB treatment and therefore treatment success could be improved using digital adherence technology. OBJECTIVE: To evaluate the effectiveness of a medication event reminder monitor system (MERM) on treatment success and treatment adherence in patients with drug-susceptible pulmonary TB in Perú. METHODS: This was an experimental, randomised, open-label, controlled study conducted among patients in the second phase of TB treatment. The intervention group received their medications through MERM with the support of a treatment monitor, whereas the control group used the usual strategy. Participants were followed until they completed the 54 doses of the second phase of treatment. RESULTS: The study included 53 patients in each group; four in the intervention group withdrew from the study. Treatment success was significantly more frequent in the MERM group (RR 1.15, 95% CI 1.02–1.30; P = 0.0322). There was no significant difference in the adherence outcomes; however, the percentage of patients who missed at least one dose and patients with more than 10% of total doses missed were lower in the intervention group. CONCLUSION: The use of MERM in the second phase of treatment showed a significant improvement in the treatment success rate in patients with drug-susceptible pulmonary TB. / National Institutes of Health / Revisión por pares
Identifer | oai:union.ndltd.org:PERUUPC/oai:repositorioacademico.upc.edu.pe:10757/659237 |
Date | 01 January 2022 |
Creators | Acosta, J., Flores, P., Alarcón, M., Grande-Ortiz, M., Moreno-Exebio, L., Puyen, Z. M. |
Publisher | International Union Against Tuberculosis and Lung Disease |
Source Sets | Universidad Peruana de Ciencias Aplicadas (UPC) |
Language | English |
Detected Language | English |
Type | info:eu-repo/semantics/article |
Format | application/pdf |
Source | Universidad Peruana de Ciencias Aplicadas (UPC), Repositorio Academico - UPC, International Journal of Tuberculosis and Lung Disease, 26, 1, 44, 49 |
Rights | info:eu-repo/semantics/openAccess, Attribution-NonCommercial-ShareAlike 4.0 International, http://creativecommons.org/licenses/by-nc-sa/4.0/ |
Relation | https://www.ingentaconnect.com/content/iuatld/ijtld/2022/00000026/00000001/art00009 |
Page generated in 0.0017 seconds